Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
Clinical trial NCT00122330 · COMPLETED
Trial details
- NCT number
- NCT00122330
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.